Project Details
Description
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 2 Study to Evaluate the Safety and Efficacy of Avacopan in Subjects with Moderate to Severe Hidradenitis Suppurativa
| Status | Finished |
|---|---|
| Effective start/end date | 8/1/19 → 8/30/24 |
Funding
- CHEMOCENTRYX, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.